1.Cerebrospinal Fluid Aspartate Aminotransferase in Alzheimer Disease and Vascular Dementia.
Journal of the Korean Geriatrics Society 2001;5(1):50-55
BACKGROUND: To evaluate usefulness of cerebrospinal aspartate aminotransferase(AST) as a biologic marker for differentiation of Alzheimer's disease(AD) and Vascular dementia(VD) METHODS: A consecutive series of patients who met either the criteria of the National Institute of Neurological Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association(NINCDSADRDA) for probable AD or National Institute of Neurological Disorders and Stroke and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences(NINDS-AIREN) criteria for porbable VD were included in the study. Enzymatic determinations in cere brospinal fluid of aspartate aminotransferase in cerebrospinal fluid of aspartate aminotransferase and serologic analysis of apolipoprotein E were performed in 17 patients with AD and in 15 patients with VD. And we compared CSF AST of AD with that of VD. RESULTS: We found no difference of CSF AST concentration between patients with Alzheimer's disease and vascular dementia. Cerebrospinal AST activity also did not correlate with K-MMSE score, serum AST activity, Functional inde-pence measure(FIM) as a ADL(Activity of daily living), and presence of Apolipoprotein E4 allele in AD. Only serum AST of VD shows correlation with CSF AST. CONCLUSION: These findings suggest that cerebrospinal AST concentration is not useful maker for differentiation between AD and VD.
Alleles
;
Alzheimer Disease*
;
Apolipoprotein E4
;
Apolipoproteins
;
Aspartate Aminotransferases*
;
Aspartic Acid*
;
Biomarkers
;
Cerebrospinal Fluid*
;
Dementia, Vascular*
;
Humans
;
National Institute of Neurological Disorders and Stroke
2.Four Cases of Pisa Syndrome in Risperidone Therapy.
Journal of the Korean Neurological Association 2000;18(1):89-93
The Pisa syndrome is a rare extrapyramidal side effect caused by neuroleptic treatment. Its characteristics are the twist-ing and bending to one side of the upper thorax, the neck, and the head. To our knowledge, there have been no reports of Pisa syndrome in risperidone therapy. We report four male patients with Pisa syndrome in risperidone therapy. Significant points to be noted here are the absence of any extrapyramidal symptoms prior to risperidone therapy, occur-rence in risperidone therapy with small dosages, and delayed spontaneous recovery on discontinuation of risperidone.
Head
;
Humans
;
Male
;
Neck
;
Risperidone*
;
Thorax
3.Differences of Spectral EEG Analysis and Prognosis Following Single Hemispheric Infarction and Hemorrhage in Striatocapsular Area.
Yong Tae KWAK ; Il Woo HAN ; Seung Han SUK
Journal of the Korean Geriatrics Society 2001;5(1):33-42
BACKGROUND: Vascular dementia is common cause of dementia, second to the dementia of Alzheimer desease. However in Asia and many developing countries, the incidence of vascular dementia exceeds that of Alzheimer's disease. Though many stroke-related factors related the nature of vascular injury, e.g. infarction and hemorrhage, have not assessed yet. Clarifying the difference of electroencephalograpy and clinical prognosis between infarction and hemorrhage, the aim of this study was to elucidate the role of nature of vascular injury. METHODS: to reduce confounding factors, the study population was restricted to the patients of single hemispheric striatocapsular infarction and hemorrhage saving cortex. On admission, we checked the KMMSE and FIM scores and using quantified EEG, we analyzed occipital peak frequency and the relative background alpha, theta and delta spectra power taken from 16 derivations by averaging twenty-2 -sec epoch in infarction, hemorrhage patients and elderly controls. After 6 months follow up, we compare the MMSE, FIM score between infarction and hemorrhage group. RESULTS: 1) Compared with infarction group, hemorrhage groups had a significantly bilateral lower occipital peak freqauency and background bilateral alpha spectra power. 2) In hemorrhage group, there is lower tendency in K-MMSE after 6 month follow up compared to infarction group. CONCLUSION: This study suggests that hemorrhage show more bilateral electrophysiological dysfunction than infarction group and possible grave prognosis for vascular dementia compared to infarction group.
Aged
;
Alzheimer Disease
;
Asia
;
Dementia
;
Dementia, Vascular
;
Developing Countries
;
Electroencephalography*
;
Follow-Up Studies
;
Hemorrhage*
;
Humans
;
Incidence
;
Infarction*
;
Prognosis*
;
Vascular System Injuries
4.Extraskeletal Neoplasm Resembling Ewing's Sarcoma: Case Report
Key Yong KIM ; Young Tae KIM ; Ho Yoon KWAK
The Journal of the Korean Orthopaedic Association 1981;16(3):712-717
Ewing's sarcoma had never been described as a primary tumor outside bone, although other malignant skeletal tumors, such as osteogenic sarcoma & chondrosarcoma, are known to arise from extraskeletal soft tissues. In 1975, Angervall & F.M. Enzinger reported 39 cases of small, round or oval cell sarcomas occuring in the soft tissues and considered histologically indistinguishable from Ewing's sarcoma of bone. Recently, We experienced one case of extraskeletal neoplasm resembling Ewing's sarcoma of bone which it was located deeply in the calf area of young female patient and the case review has been followed until the death, approxlmately 10.5 months after removal.
Chondrosarcoma
;
Female
;
Humans
;
Osteosarcoma
;
Sarcoma
;
Sarcoma, Ewing
5.A Case of Metronome Pisa Syndrome in Risperidone Therapy.
Journal of Korean Neuropsychiatric Association 2000;39(1):229-233
The Pisa syndrome is a rare extrapyramidal side effect caused by neuroleptic treatment and its characteristics are twisting and bending to one side of the upper thorax, the neck and the head. When its chatacteristics show both sides, we call it 'Metronome Pisa syndrome'. We report the case of a 53-year-old woman who suffered Metronome Pisa syndrome following risperidone therapy. Risperidone therapy in old ages should be cautious even if its dosage is minimal.
Female
;
Head
;
Humans
;
Middle Aged
;
Neck
;
Risperidone*
;
Thorax
6.Two Cases of Discontinuation Syndrome Following Cessation of Cholinesterase Inhibitors.
Journal of the Korean Neurological Association 2004;22(4):386-388
Discontinuation syndrome is a cluster of symptoms that appear when a patient terminates long-term medication. We report 2 patients with Alzheimer's disease who developed significant behavioral disturbances after the cessation of cholinesterase inhibitors. Although the clinical profile of discontinuation syndrome in cholinesterase inhibitors are yet poorly defined, it may be of importance to consider this syndrome when patients develop significant behavioral disturbances after these agents are stopped, and if more severe reactions are expected, retrial of these agents may be prudent.
Alzheimer Disease
;
Cholinesterase Inhibitors*
;
Cholinesterases*
;
Humans
7.Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naive Alzheimer's Disease.
Yong Tae KWAK ; Youngsoon YANG ; Soon Gu KWAK
Dementia and Neurocognitive Disorders 2012;11(3):87-94
BACKGROUND: Behavioral and psychological symptoms of dementia (BPSD) are less well-defined aspects of Alzheimer's disease (AD). We designed this study to explore the followings: 1) the clinical profiles of BPSD 2) the clustered-groups domains of the Korean-Neuropsychiatric Inventory (K-NPI) assessment of BPSD 3) the clinical characteristics of the clustered-groups of BPSD in patients with drug-naive probable AD. METHODS: Descriptive and cluster analyses of the 12 K-NPI domains were done in 220 patients with drug-naive probable AD. After clustering these domains, characteristics of these positive symptoms clustered-group of patients were compared with the negative symptoms groups of patients. RESULTS: The mean Korean-Mini Mental Status Examination (K-MMSE), Clinical Dementia Rating (CDR) scale, and K-NPI scores were 15.0, 1.6, and 14.2, respectively. The CDR and K-MMSE scores correlated with total K-NPI scores, and depression was the most common symptom. According to cluster analysis, five major clusters were identified. Using the associated neuropsychological dysfunctions, characteristics of each group were defined. CONCLUSIONS: This study identified the clustered-domains for K-NPI, and suggested the possible anatomical substrates for these groups in drug-naive AD patients. These attempts may clarify the complex and bizarre behavioral and psychological symptoms as more neurologically relevant symptoms.
Alzheimer Disease
;
Cluster Analysis
;
Dementia
;
Deoxycytidine
;
Depression
;
Humans
8.Neurocognitive Model of Delusion: Two-Factor Theory.
Journal of the Korean Neurological Association 2016;34(1):1-13
The underlying nature of delusions remains unclear despite their importance in psychopathology. Here we present a review of the neurocognitive model of delusions from a cognitive neuroscience viewpoint. There have been numerous reports on cognitive impairments in delusional patients, such as in their reasoning, attention, metacognition, and attribution biases. These findings have been incorporated into several cognitive models that aim to explain the formation, maintenance, and content of delusion. Although delusions are commonly conceptualized as beliefs, not all models make reference to models of normal belief formation. This review focused on two-factor theory models that make a distinction between factors that explain the content of delusions and those that explain their presence. This cognitive theory that includes the 'pragmatic pathology' of delusions can address both the phenomenology and treatment of delusion-related distress.
Bias (Epidemiology)
;
Delusions*
;
Humans
;
Neurosciences
;
Psychopathology
9.Quantitative EEG findings in different stage of Alzheimer's Disease.
Journal of the Korean Neurological Association 2005;23(3):356-362
BACKGROUND: Although quantitative-electroencephalography (q-EEG) has been used for many years to differentiate Alzheimer's disease (AD) from the healthy aging process, the electrophysiological changes of AD has not been well established due to progressive nature of AD. The aim of this study was to compare q-EEG parameters among elderly controls, patients with mild cognitive impairment group (MCI), and patients with four different stages of AD. Moreover, we tried to identify the variables that are correlated with the degree of cognitive impairment. METHODS: After logarithmic transformation of relative spectral power, we analyzed the topographical relative spectral power and occipital peak frequency in each group. Multiple regression analysis was applied to these variables to identify parameters related with K-MMSE. RESULTS: (1) In AD patients with less than CDR 0.5, peak frequency in occipital lead was significantly lower than that of elderly controls. (2) Compared with elderly controls, AD patients showed significantly reduced left anterior alpha spectral power in CDR 0.5, increased bilateral posterior theta spectral power and reduced generalized alpha spectral power in CDR 1, generalized reduced alpha, beta spectral power and increased theta spectral power in CDR2, generalized reduced alpha and beta spectral power, increased delta and theta spectral power in CDR 3. (3) Korean Mini-Mental State Examination (K-MMSE) score was closely related to left occipital peak frequency, right posterior delta and left anterior theta spectral power. CONCLUSIONS: This study suggests that q-EEG shows different findings in different stages of AD and the left occipital peak frequency is closely correlated with the severity of cognitive dysfunction.
Aged
;
Aging
;
Alzheimer Disease*
;
Electroencephalography*
;
Humans
;
Mild Cognitive Impairment
;
Regression Analysis
10.Olanzapine-induced Neuroletpic Malignant Syndrome.
Journal of the Korean Neurological Association 2000;18(2):249-251
We report a case of atypical neuroleptic malignant syndrome (NMS) induced by olanzapine. It was expected that this atypical agent would not cause dystonia or NMS due to its unique mechanism of action with attenuated anti-dopamin-ergic activity and potentiated antiserotonergic activity, as well as other anti-cholinergic activity. We report the case of a 74-year-old male patient with Alzheimer's disease in whom signs and symptoms consistent with NMS developed following 2 weeks of olanzapine therapy. The patient presented with fever, changes in mental status, tremor, and rigidity. His laboratory findings were significant for increased serum creatine phosphokinase. The NMS subsided after treatment and the restart of olanzapine therapy was performed successfully. There have been few reported cases of olanzapine-induced NMS. Health care providers should be aware of the risk of olanzapine-induced NMS.
Aged
;
Alzheimer Disease
;
Creatine Kinase
;
Dystonia
;
Fever
;
Health Personnel
;
Humans
;
Male
;
Neuroleptic Malignant Syndrome
;
Tremor